Russia to supply another batch of transport helicopters to China in 2018Business & Economy July 21, 11:47
All four turbines produced by Siemens delivered to Crimea despite agreementsBusiness & Economy July 21, 10:11
Records file on Gagarin flight fetches nearly $50,000 at Sotheby’sSociety & Culture July 21, 10:00
Russian-Chinese naval exercises kick off in Baltic SeaMilitary & Defense July 21, 9:47
IMF Executive Board decides on $1.8 billion conditional loan for GreeceBusiness & Economy July 21, 3:34
Turkey’s western coast rocked by 6.7 magnitude quakeWorld July 21, 2:58
ExxonMobil launches legal challenge to finding it violated US sanctions against RussiaBusiness & Economy July 21, 1:36
Russian Knights aerobatic team to perform at Dubai airshowMilitary & Defense July 20, 21:28
Russia looks to its Navy to become world secondMilitary & Defense July 20, 19:10
MOSCOW, May 27. /TASS/. Doping test result of Russian heavyweight boxer Alexander Povetkin, who Sample B tested positive for banned substance meldonium, was not unexpected news and his team was ready for it, Andrei Ryabinsky, the head of the Boxing World promotion company told TASS on Friday.
"It was expected," Ryabinsky said in an interview with TASS. "We never denied that it [meldonium] was there [in Povetkin’s blood]."
WBC Heavyweight Champion Deontay Wilder of the United States (W36-L0, 35 KOs) was scheduled to hold his mandatory title bout against Povetkin (30-1, 22 KOs) on May 21 in Moscow, However, Russian boxer’s doping Sample A had tested positive for meldonium shortly before the fight and the bout was suspended indefinitely.
"This story is about the low concentration of detected meldonium," Ryabinsky said. "However, nobody ever denied that it was present in the [doping] samples."
The found drug in the body system of the 36-year-old Russian fighter was in low concentration of 0.07 micrograms. US sports channel ESPN later reported that before the positive doping result, Povetkin passed doping tests three times, namely on April, 7,8 and 11, and all his samples tested negative. However, his doping test as of April 27 gave a positive indication for meldonium presence in his blood.
Wilder’s management announced earlier it intended to demand from the Russian side a financial compensation of $4.6 million in case the bout was eventually cancelled.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
However, on April 13, WADA announced that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.